<DOC>
	<DOCNO>NCT01098097</DOCNO>
	<brief_summary>To study retreatment patient fail prior treatment interferon alpha ( pegylated non-pegylated ) without ribavirin real-life set observational/noninterventional study .</brief_summary>
	<brief_title>Post Marketing Observational Study Retreatment Chronic Hepatitis C With Peginterferon Alpha Ribavirin ( Study P06011 )</brief_title>
	<detailed_description>This observational/non interventional study collect data patient characteristic seek retreatment well safety efficacy information first 12 week retreatment .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Chronic hepatitis C genotype ; Prior treatment interferon alpha ( pegylated nonpegylated ) without ribavirin result sustain virological response ; Inclusion criterion list approve label country ; Willingness patient participate sign Informed Consent Form . Patient exclusion observational/noninterventional study determine treat physician base local label country .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>